Paper Review Records
All Paper Review Records
27 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
159
days
Immune reconstitution and clinical outcomes in B-ALL patients with versus without pre-HSCT Immunotherapy
Authors
Yu-Yuan Zeng; Guan-Hua Hu; Ying-Xi Zuo; Pan Suo; Lu Bai; Feng Zhang; Hui-Fang Wang; Ying-Jun Chang; Meng Lv; Xiao-Hui Zhang; Yu Wang; Lan-Ping Xu; Xiao-Jun Huang; Lin Wang; Yi-Fei ChengShow moreShow less
Affiliations
1. Department of Child Health Care, Capital Center for Children’s Health, Capital Medical University, Beijing, China; 2. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, ChinaShow moreShow less
148
days
Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
Authors
Meletios Athanasios Dimopoulos; Vania Hungria; Haitao Meng; Atanas Radinoff; Jian Li; Sosana Delimpasi; Ting Niu; Gabor Mikala; Tamas Masszi; Marcelo Capra; Michael Low; Angelo Maiolino; Yan Xu; Xavier Leleu; Vasiliki Pappa; Dominik Chraniuk; Tatiana Konstantinova; Iurii Osipov; Shawn Hakim; Chris Brawley; Gabriela Tubel; Astrid McKeown; Julia Boyle; Sumita Roy-Ghanta; Katja WeiselShow moreShow less
Affiliations
1. National and Kapodistrian University of Athens, Athens, Greece; 2. Korea University, Seoul, South Korea; 3. Department of Hematology, Clinica São Germano São Paulo, São Paulo, Brazil; 4. The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 5. University Hospital “St Ivan Rilski” EAD, Sofia, Bulgaria; 6. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 7. General Hospital Evangelismos, Athens, Greece; 8. West China Hospital of Sichuan University, Chengdu, China; 9. South Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary; 10. Semmelweis University Department of Internal Medicine and Hematology, Budapest, Hungary; 11. Centro Gaúcho Integrado de Pesquisa, Hospital Mãe de Deus, Porto Alegre, Brazil; 12. Monash Haematology, Monash University, Clayton University, Victoria, Australia; 13. Instituto Americas de Ensino, Pesquisa e Inovacao, Rio de Janeiro, Brazil; 14. Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 15. Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China; 16. Hospital of Poitiers, Poitiers, France; 17. Second Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Athens, Greece; 18. Department of Hematology, Wojewodzki Szpital Zespolony, Torun, Poland; 19. Regional Clinical Hospital No 1, Ekaterinburg, Russian Federation; 20. V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation; 21. GSK, Upper Providence, USA; 22. GSK, London, UK; 23. GSK, Stevenage, UK; 24. University Medical Center of Hamburg-Eppendorf, Hamburg, GermanyShow moreShow less
79
days
Improving survival and narrowing age disparities in mantle cell lymphoma across therapeutic eras
Authors
Malak Munir; John L. Vaughn; Sravani Rimmalapudi; Narendranath EpperlaShow moreShow less
Affiliations
1. Department of Medicine, Rochester General Hospital, Rochester, USA; 2. Division of Hematology & Oncology, Westchester Medical Center, Valhalla, USA; 3. Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, USAShow moreShow less
128
days
Glucagon-like peptide-1 receptor agonists and risk for hematologic malignancies: a multicenter propensity score-matched analysis
Authors
Pratik Shah; Adit Singhal; Tsu Hsien Wang; Albert Ko; Yu-Cheng Chang; Anita Ng; Andrew Shih; Yuan Ping Hsia; Cho-Hung Chiang; Cho-Han ChiangShow moreShow less
Affiliations
1. Northwell Health Cancer Institute, Lake Success, USA; 2. Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, USA; 3. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; 4. Department of Medicine, Danbury Hospital, Danbury, USA; 5. Feinstein Institutes for Medical Research, Manhasset, USA; 6. Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 7. Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanShow moreShow less
114
days
A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma
Authors
Ricardo Ahrens; Kyra Ahrens; Maximilian Al-Bazaz; Lisa Leypoldt; Carsten Bokemeyer; Winfried Alsdorf; Katja WeiselShow moreShow less
Affiliations
1. Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Knowledge Technology Group, Department of Informatics, University of Hamburg, Hamburg, GermanyShow moreShow less
79
days
Clinicomolecular features and clonal evolution of KMT2A -PTD AML: prognostic impact of concurrent FLT3 -ITD under 2022 ELN risk stratification
Authors
Yi-Tsung Yang; Chi-Yuan Yao; Yong-Huai Yi; Chein-Jun Kao; Yuan-Yeh Kuo; Ming-En Lin; Hsin-An Hou; Chien-Chin Lin; Wen-Chien Chou; Hwei-Fang TienShow moreShow less
Affiliations
1. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 2. Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; 3. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4. Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan; 5. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; 6. Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, TaiwanShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
